Pathogenesis of influenza-induced acute respiratory distress syndrome

The Lancet Infectious Diseases

Volumn 14, Issue 1, 2014, Pages 57-69

  Short, Kirsty R ^a   Kroeze, Edwin J B Veldhuis ^a   Fouchier, Ron A M ^a   Kuiken, Thijs ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MYELOPEROXIDASE; NITRIC OXIDE; PHOSPHOLIPASE; PROTEIN KINASE C; RANTES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; CYSTIC FIBROSIS; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; LEUKOCYTE; LUNG ALVEOLUS CELL; LUNG EDEMA; MACROPHAGE; NEUTROPHIL; NONHUMAN; OSMOTIC PRESSURE; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION;

EID: 84890425082     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70286-X     Document Type: Review

References (140)

1. Fiers W, De Filette M, Birkett A, Neirynck S, Min Jou W A "universal" human influenza A vaccine. Virus Res 2004, 103:173-176.
2. Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012, 9:687-695.
3. Johnson N, Mueller J Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 2002, 76:105-115.
4. Webster RG, Peiris M, Chen H, Guan Y H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 2006, 12:3-8.
5. Horby P H7N9 is a virus worth worrying about. Nature 2013, 496:399.
6. Morens D, Taubenberger J, Fauci A Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008, 198:962-970.
7. Brundage JF, Shanks GD Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis 2008, 14:1193. 1119.
8. Chien YW, Klugman KP, Morens DM Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med 2009, 361:2582-2583.
9. Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 2009, 4:e8540.
10. Okada T, Morozumi M, Matsubara K, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother 2010, 17:1-8.
11. Kuiken T, Taubenberger JK Pathology of human influenza revisited. Vaccine 2008, 26:D59-D66.
12. Morens DM, Fauci AS The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 2007, 195:1018-1028.
13. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005, 11:201.
14. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013, 368:1888-1897.
15. To KK, Hung IF, Li IW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010, 50:850-859.
16. Ramsey C, Kumar A H1N1: viral pneumonia as a cause of acute respiratory distress syndrome. Curr Opin Crit Care 2011, 17:64-71.
17. Husain AN, Kumar V The lung. Robbins & Cotran Pathologic Basis of Disease 2010, 715-716. Elsevier, Pennsylvania, PA. 8th edn. V. Kumar, A. Abbas, N. Fausto (Eds.).
18. Piantadosi CA, Schwartz DA The acute respiratory distress syndrome. Ann Intern Med 2004, 141:460-470.
19. Bannerman DD, Goldblum SE Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 2003, 284:L899-L914.
20. Matthay MA, Zemans RL The acute respiratory distress syndrome: pathogenesis and treatment. Ann Rev Pathol 2011, 6:147-163.
21. Basler CF, Aguilar PV Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. Antiviral Res 2008, 79:166-178.
22. Peiris JSM, Cheung CY, Leung CYH, Nicholls JM Innate immune responses to influenza A H5N1: friend or foe?. Trends Immunol 2009, 30:574-584.
23. Taubenberger JK, Morens DM The pathology of influenza virus infections. Ann Rev Pathol 2008, 3:499-522.
24. Koval M Claudin heterogeneity and control of lung tight junctions. Annu Rev Physiol 2013, 75:551-567.
25. Gorin AB, Stewart PA Differential permeability of endothelial and epithelial barriers to albumin flux. J Appl Physiol 1979, 47:1315-1324.
26. Folkesson HG, Matthay MA Alveolar epithelial ion and fluid transport: recent progress. Am J Respir Cell Mol Biol 2006, 35:10-19.
27. Berthiaume Y, Matthay MA Alveolar edema fluid clearance and acute lung injury. Respir Physiol Neurobiol 2007, 159:350-359.
28. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y Avian flu: influenza virus receptors in the human airway. Nature 2006, 440:435-436.
29. van Riel D, Munster V, de Wit E, et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 2007, 171:1215-1223.
30. Van Riel D, Munster VJ, De Wit E, et al. H5N1 virus attachment to lower respiratory tract. Science 2006, 312:399.
31. Nakajima N, Van Tin N, Sato Y, et al. Pathological study of archival lung tissues from five fatal cases of avian H5N1 influenza in Vietnam. Modern Pathol 2012, 26:357-369.
32. Uiprasertkul M, Puthavathana P, Sangsiriwut K, et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005, 11:1036-1041.
33. Guarner J, Falcón-Escobedo R Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res 2009, 40:655-661.
34. Childs RA, Palma AS, Wharton S, et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotech 2009, 27:797-799.
35. Shieh W-J, Blau DM, Denison AM, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 2010, 177:166-175.
36. Stevens J, Blixt O, Glaser L, et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 2006, 355:1143-1155.
37. Chutinimitkul S, van Riel D, Munster VJ, et al. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol 2010, 84:6825-6833.
38. Chen X-J, Seth S, Yue G, et al. Influenza virus inhibits ENaC and lung fluid clearance. Am J Physiol Lung Cell Mol Physiol 2004, 287:L366-L373.
39. Kunzelmann K, Beesley A, King N, Karupiah G, Young J, Cook D Influenza virus inhibits amiloride-sensitive Na+ channels in respiratory epithelia. Proc Natl Acad Sci USA 2000, 97:10282-10287.
40. Lazrak A, Iles KE, Liu G, Noah DL, Noah JW, Matalon S Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species. FASEB J 2009, 23:3829-3842.
41. Wolk KE, Lazarowski ER, Traylor ZP, et al. Influenza A virus inhibits alveolar fluid clearance in BALB/c mice. Am J Respir Crit Care Med 2008, 178:969-976.
42. Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010, 181:72-79.
43. Uiprasertkul M, Kitphati R, Puthavathana P, et al. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis 2007, 13:708-712.
44. Brydon EW, Smith H, Sweet C Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release. J Gen Virol 2003, 84:2389-2400.
45. Arndt U, Wennemuth G, Barth P, et al. Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J Virol 2002, 76:9298-9306.
46. Lam W, Tang JW, Yeung AC, Chiu LC, Sung JJ, Chan PK Avian influenza virus A/HK/483/97 (H5N1) NS1 protein induces apoptosis in human airway epithelial cells. J Virol 2008, 82:2741-2751.
47. Takizawa T, Ohashi K, Nakanishi Y Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J Virol 1996, 70:8128-8132.
48. Schultz-Cherry S, Hinshaw VS Influenza virus neuraminidase activates latent transforming growth factor beta. J Virol 1996, 70:8624-8629.
49. Kash JC, Goodman AG, Korth MJ, Katze MG Hijacking of the host-cell response and translational control during influenza virus infection. Virus Res 2006, 119:111-120.
50. Golebiewski L, Liu H, Javier RT, Rice AP The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions. J Virol 2011, 85:10639-10648.
51. Peiris J, Yu W, Leung C, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004, 363:617-619.
52. Choi AM, Jacoby DB Influenza virus A infection induces interleukin-8 gene expression in human airway epitheial cells. FEBS Lett 1992, 309:327-329.
53. Chan M, Cheung C, Chui W, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005, 6:135.
54. Herold S, von Wulffen W, Steinmueller M, et al. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol 2006, 177:1817-1824.
55. Guillot L, Le Goffic R, Bloch S, et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 2005, 280:5571-5580.
56. Zeng H, Goldsmith CS, Maines TR, et al. Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures. J Virol 2013, 87:2597-2607.
57. Bernasconi D, Amici C, La Frazia S, Ianaro A, Santoro MG The IκB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. J Biol Chem 2005, 280:24127-24134.
58. Veckman V, Österlund P, Fagerlund R, Melén K, Matikainen S, Julkunen I TNF-α and IFN-α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virol 2006, 345:96-104.
59. Adachi M, Matsukura S, Tokunaga H, Kokubu F Expression of cytokines on human bronchial epithelial cells induced by influenza virus A. Int Arch Allergy Immunol 2009, 113:307-311.
60. Matsukura S, Kokubu F, Noda H, Tokunaga H, Adachi M Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol 1996, 98:1080-1087.
61. Roux J, Kawakatsu H, Gartland B, et al. Interleukin-1β decreases expression of the epithelial sodium channel α-subunit in alveolar epithelial cells via a p38 MAPK-dependent signaling pathway. J Biol Chem 2005, 280:18579-18589.
62. Mullin JM, Snock KV Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 1990, 50:2172-2176.
63. Wyble CW, Hynes KL, Kuchibhotla J, Marcus BC, Hallahan D, Gewertz BL TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway. J Surg Res 1997, 73:107-112.
64. Pinkerton KE, Gehr P, Crapo JD Architecture and cellular composition of the air-blood barrier. Comparative biology of the lung 1992, 121-128. CRC Press, Boca Raton, FL. R.A. Parent (Ed.).
65. Zeng H, Pappas C, Belser JA, et al. Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection. J Virol 2012, 86:667-678.
66. Ocaña-Macchi M, Bel M, Guzylack-Piriou L, et al. Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells. J Virol 2009, 83:12947-12955.
67. Perrone LA, Plowden JK, García-Sastre A, Katz JM, Tumpey TM H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008, 4:e1000115.
68. Visseren F, Verkerk M, Bouter K, Diepersloot R, Erkelens D Interleukin-6 production by endothelial cells after infection with influenza virus and cytomegalovirus. J Lab Clin Med 1999, 134:623-630.
69. Ishiguro N, Takada A, Yoshioka M, et al. Induction of interferon-inducible protein-10 and monokine induced by interferon-γ from human endothelial cells infected with influenza A virus. Arch Virol 2003, 149:17-34.
70. Teijaro JR, Walsh KB, Cahalan S, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011, 146:980-991.
71. Armstrong SM, Wang C, Tigdi J, et al. Influenza infects lung microvascular endothelium leading to microvascular leak: role of apoptosis and claudin-5. PLoS One 2012, 7:e47323.
72. Armstrong SM, Darwish I, Lee WL Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection. Virulence 2013, 4:537-542.
73. Alexander DJ A review of avian influenza in different bird species. Vet Microbiol 2000, 74:3-13.
74. Wiener-Kronish J, Albertine K, Matthay M Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest 1991, 88:864-875.
75. Sumikoshi M, Hashimoto K, Kawasaki Y, et al. Human influenza virus infection and apoptosis induction in human vascular endothelial cells. J Med Virol 2008, 80:1072-1078.
76. Chan M, Chan R, Yu W, et al. Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells. Respir Res 2009, 10:102.
77. Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007, 370:1137-1145.
78. Kuiken T, Van Den Brand J, Van Riel D, Pantin-Jackwood M, Swayne D Comparative pathology of select agent influenza A virus infections. Vet Pathol 2010, 47:893-914.
79. Reperant LA, van de Bildt MW, van Amerongen G, et al. Marked endotheliotropism of highly pathogenic avian influenza virus H5N1 following intestinal inoculation in cats. J Virol 2012, 86:1158-1165.
80. Huber D, Balda MS, Matter K Transepithelial migration of neutrophils. Invasion Metastasis 1999, 18:70-80.
81. Walker DC, Behzad AR, Chu F Neutrophil migration through preexisting holes in the basal laminae of alveolar capillaries and epithelium during streptococcal pneumonia. Microvasc Res 1995, 50:397-416.
82. Martin TR, Pistorese BP, Chi E, Goodman R, Matthay M Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 1989, 84:1609-1619.
83. Jaeschke H, Smith CW Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997, 61:647-653.
84. Tapper H The secretion of preformed granules by macrophages and neutrophils. J Leukoc Biol 1996, 59:613-622.
85. Stinchcombe JC, Griffiths GM Regulated secretion from hemopoietic cells. J Cell Biol 1999, 147:1-5.
86. von Köckritz-Blickwede M, Nizet V Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J Mol Med 2009, 87:775-783.
87. Tate MD, Deng Y-M, Jones JE, Anderson GP, Brooks AG, Reading PC Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol 2009, 183:7441-7450.
88. Weiland JE, Davis WB, Holter JF, Mohammed J, Dorinsky P, Gadek J Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis 1986, 133:218-225.
89. Sakai S, Kawamata H, Mantani N, et al. Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice. J Virol 2000, 74:2472-2476.
90. Narasaraju T, Yang E, Samy RP, et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 2011, 179:199-210.
91. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A Neutrophil function: from mechanisms to disease. Annu Rev Immunol 2012, 30:459-489.
92. Bandyopadhyay U, Das D, Banerjee RK Reactive oxygen species: oxidative damage and pathogenesis. Curr Sci 1999, 77:658-666.
93. Fang FC Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004, 2:820-832.
94. Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, Maeda H Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 1989, 244:974-976.
95. Snelgrove RJ, Edwards L, Rae AJ, Hussell T An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol 2006, 36:1364-1373.
96. Lefkowitz DL, Mills K, Lefkowitz S, Bollen A, Moguilevsky N Neutrophil-macrophage interaction: a paradigm for chronic inflammation. Med Hypotheses 1995, 44:58-62.
97. Yamamoto K, Miyoshi-Koshio T, Utsuki Y, Mizuno S, Suzuki K Virucidal activity and viral protein modification by myeloperoxidase: a candidate for defense factor of human polymorphonuclear leucocytes against influenza virus infection. J Infect Dis 1991, 164:8-14.
98. Vissers M, Pullar JM, Hampton MB Hypochlorous acid causes caspase activation and apoptosis or growth arrest in human endothelial cells. Biochem J 1999, 344:443-449.
99. Sugamata R, Dobashi H, Nagao T, et al. Contribution of neutrophil-derived myeloperoxidase in the early phase of fulminant acute respiratory distress syndrome induced by influenza virus infection. Microbiol Immunol 2012, 56:171-182.
100. Wang JP, Bowen GN, Padden C, et al. Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 2008, 112:2028-2034.
101. Ichikawa A, Kuba K, Morita M, et al. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med 2013, 187:65-77.
102. Cameron CM, Cameron MJ, Bermejo-Martin JF, et al. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J Virol 2008, 82:11308-11317.
103. Hemmers S, Teijaro JR, Arandjelovic S, Mowen KA PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS One 2011, 6:e22043.
104. Valberg PA, Blanchard JD Pulmonary macrophage physiology: origin, motility, endocytosis. Comparative biology of the lung 1992, 681-724. CRC Press, Boca Raton, FL. R.A. Parent (Ed.).
105. Holt P Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages. Clin Exp Immunol 1986, 63:261-270.
106. Tate MD, Pickett DL, van Rooijen N, Brooks AG, Reading PC Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol 2010, 84:7569-7580.
107. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 2000, 156:1951-1959.
108. Herold S, Steinmueller M, von Wulffen W, et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 2008, 205:3065-3077.
109. Hogner K, Wolff T, Pleschka S, et al. Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog 2013, 9:e1003188.
110. Padalko E, Ohnishi T, Matsushita K, et al. Peroxynitrite inhibition of Coxsackievirus infection by prevention of viral RNA entry. Proc Natl Acad Sci USA 2004, 101:11731-11736.
111. Szabo C Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 2003, 140:105-112.
112. Akaike T, Noguchi Y, Ijiri S, et al. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 1996, 93:2448-2453.
113. Karupiah G, Chen J-H, Mahalingam S, Nathan CF, MacMicking JD Rapid interferon γ-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J Exp Med 1998, 188:1541-1546.
114. Pirhonen J, Sareneva T, Kurimoto M, Julkunen I, Matikainen S Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol 1999, 162:7322-7329.
115. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 2002, 360:1831-1837.
116. Lehmann C, Sprenger H, Nain M, Bacher M, Gemsa D Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-α (TNFα) gene expression. Res Virol 1996, 147:123-130.
117. Hui KP, Lee SM, Cheung C-y, et al. Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J Immunol 2009, 182:1088-1098.
118. Matikainen S, Pirhonen J, Miettinen M, et al. Influenza A and Sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virol 2000, 276:138-147.
119. Geiler J, Michaelis M, Sithisarn P, Cinatl J Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med Microbiol Immunol 2011, 200:53-60.
120. Woo PC, Tung ET, Chan K-H, Lau CC, Lau SK, Yuen K-Y Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J Infect Dis 2010, 201:346-353.
121. Yu WC, Chan RW, Wang J, et al. Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J Virol 2011, 85:6844-6855.
122. Michaelis M, Geiler J, Naczk P, et al. Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages. Med Microbiol Immunol 2010, 199:291-297.
123. Osterlund P, Pirhonen J, Ikonen N, et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 2010, 84:1414-1422.
124. Friesenhagen J, Boergeling Y, Hrincius E, Ludwig S, Roth J, Viemann D Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages. J Leukoc Biol 2012, 92:11-20.
125. Mok KP, Wong CH, Cheung CY, et al. Viral genetic determinants of H5N1 influenza viruses that contribute to cytokine dysregulation. J Infect Dis 2009, 200:1104-1112.
126. van Riel D, Leijten LM, van der Eerden M, et al. Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction. PLoS Pathog 2011, 7:e1002099.
127. Hale BG, Albrecht RA, García-Sastre A Innate immune evasion strategies of influenza viruses. Future Microbiol 2010, 5:23-41.
128. Seo SH, Hoffmann E, Webster RG Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 2002, 8:950-954.
129. Salomon R, Hoffmann E, Webster RG Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 2007, 104:12479-12481.
130. Szretter KJ, Gangappa S, Lu X, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007, 81:2736-2744.
131. Sevransky JE, Martin GS, Shanholtz C, et al. Mortality in sepsis versus non-sepsis induced acute lung injury. Crit Care 2009, 13:R150.
132. Sheu C-C, Gong MN, Zhai R, et al. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest 2010, 138:559-567.
133. Brunkhorst FM, Eberhard OK, Brunkhorst R Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 1999, 27:2172-2176.
134. Budinger G, Sznajder JI The alveolar-epithelial barrier: a target for potential therapy. Clin Chest Med 2006, 27:655-669.
135. Darwish I, Mubareka S, Liles WC Immunomodulatory therapy for severe influenza. Expert Rev Anti Infect Ther 2011, 9:807-822.
136. Narasaraju T, Ng H, Phoon M, Chow VT MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. Am J Respir Cell Mol Biol 2010, 42:732-743.
137. Vlahos R, Stambas J, Bozinovski S, Broughton BR, Drummond GR, Selemidis S Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog 2011, 7:e1001271.
138. Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133:235-249.
139. Zheng BJ, Chan KW, Lin YP, et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci USA 2008, 105:8091-8096.
140. Bellingan G The pulmonary physician in critical care. 6: the pathogenesis of ALI/ARDS. Thorax 2002, 57:540-546.